Kappac Pharma Ltd - Stock Valuation and Financial Performance

BSE: 506938 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Kappac Pharma

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

2. Valuation

Undervalued

3. Price Trend

Kappac Pharma stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
341.5 Cr.
52-wk low:
112.9
52-wk high:
112.9

Is Kappac Pharma Ltd an attractive stock to invest in?

1. Is Kappac Pharma Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Kappac Pharma Ltd is a below average quality company.

2. Is Kappac Pharma Ltd undervalued or overvalued?

No data found

3. Is Kappac Pharma Ltd a good buy now?

No data found

10 Year X-Ray of Kappac Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Kappac Pharma Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14TTM
ROCE % -12.9%-77.7%-37.3%190.3%-91%-0.2%-0.3%-0.2%-0.3%-0.3%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 3.40.8002000000
Sales YoY Gr.--77.5%-100%NANA-100%NANANANA-
Adj EPS -2-7.9-1.83.60-0.2-0-0-0-0-0.7
YoY Gr.-NANANA-100%NANANANANA-
BVPS (₹) 13.15.13.7-0-012.510.110.110.112.612.6
Adj Net
Profit
-0.2-0.6-0.10.300-0.1-0.1-0.1-0.1-2
Cash Flow from Ops. -0.7-0.10-0.30-16.8-0.7-0.1-4.44.2-
Debt/CF from Ops. -0-0.2-0.60-1-00-4300.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -100%-100%NANA
Adj EPS NANANANA
BVPS-0.4%NA7.6%25.3%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14TTM
Return on
Equity %
-13.4-79.6-38.6196.4-15.9-0.2-0.3-0.3-0.4-0.3-5.8
Op. Profit
Mgn %
-2.3-100.500000000NAN
Net Profit
Mgn %
-4.6-79.800000000-INF
Debt to
Equity
0000-1.80.100.1000
Working Cap
Days
6391,508004000000
Cash Conv.
Cycle
-302-74100-94000000

Recent Performance Summary

No data to display

Return on Equity is Poor

Sales growth has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Kappac Pharma Ltd.

Standalone Consolidated
TTM EPS (₹) -0.7 -
TTM Sales (₹ Cr.) 0 -
BVPS (₹.) 12.6 -
Reserves (₹ Cr.) 8 -
P/BV 8.97 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 112.85 / 112.85
All Time Low / High (₹) 3.20 / 734.75
Market Cap (₹ Cr.) 341
Equity (₹ Cr.) 30.3
Face Value (₹) 10
Industry PE 47.6

Management X-Ray of Kappac Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Kappac Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14
Sales3100200000
Operating Expenses 3201200000
Manufacturing Costs1000000000
Material Costs2000200000
Employee Cost 1100000000
Other Costs 0001000000
Operating Profit 0-10-1000000
Operating Profit Margin (%) -2.3%-100.0%--0.0%-----
Other Income 0001000000
Interest 0000000000
Depreciation 0000000000
Exceptional Items 0000000000
Profit Before Tax 0-100000000
Tax 0000000000
Profit After Tax 0-100000000
PAT Margin (%) -4.5%-78.4%--0.0%-----
Adjusted EPS (₹)-2.0-7.7-1.8-3.70.0-0.20.00.00.00.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14

Equity and Liabilities

Shareholders Fund 10000124242438
Share Capital 11111124242430
Reserves 000-1-100008
Minority Interest0000000000
Debt0000000300
Long Term Debt0000000000
Short Term Debt0000000300
Trade Payables4341110000
Others Liabilities 00000160000
Total Liabilities 544111724272439

Fixed Assets

Gross Block2220000000
Accumulated Depreciation1110000000
Net Fixed Assets1110000000
CWIP 0000000000
Investments 00111411141919
Inventories0000000000
Trade Receivables0000000050
Cash Equivalents 0000000000
Others Assets33300131313019
Total Assets 544111724272439

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14
Cash Flow From Operating Activity -10000-17-10-44
PBT 0-100000000
Adjustment 0001000000
Changes in Working Capital -100-1-0-17-1-0-44
Tax Paid 0000000000
Cash Flow From Investing Activity 000000-7-3-50
Capex 0001000-3-50
Net Investments 000000-7000
Others 000-1000000
Cash Flow From Financing Activity 00000177310-4
Net Proceeds from Shares 0000007000
Net Proceeds from Borrowing 0000000000
Interest Paid 0000000000
Dividend Paid 0000000000
Others 00000170310-4
Net Cash Flow -1000000000
PARTICULARSMar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14
Ratios
ROE (%)-14.4N/AN/AN/AN/A-2.79-0.42-0.26-0.35-0.27
ROCE (%)-16.26N/AN/AN/AN/A-0.16-0.26-0.24-0.33-0.27
Asset Turnover Ratio0.430.16003.6500000
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days389700900000
Inventory Days55000000000
Payable Days7882,946009800000

Kappac Pharma Ltd Stock News

Kappac Pharma Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Kappac Pharma on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Kappac Pharma stood at ₹341.5.
The latest P/E ratio of Kappac Pharma as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Kappac Pharma as of 01-Jan-1970 05:30 is 8.97.
The 52-week high of Kappac Pharma is ₹112.8 and the 52-week low is ₹112.8.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Kappac Pharma is ₹0.00 ( Cr.) .

About Kappac Pharma Ltd

Kappac Pharma was incorporated in the year 1981 and has been engaged in the manufacture of pharmaceutical products. Located in the Thane district of Maharashtra, the manufacturing unit has capacity to produce capsules, tablets and syrups. The registered office is located at E-15, Nisarag Heaven Building, Dahanukar Wadi, Mahavir Nagar, Mumbai 400067.

Business areas of the company:

The company engages in the manufacture of pharmaceutical products.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.